Posted on August 22, 2026 by pervial Retatrutide (LY3437943): Mechanisms, Evidence, and Research Potential of the GIP/GLP-1/Glucagon Tri-Agonist A comprehensive scientific overview of Retatrutide (LY3437943), detailing its novel triple-receptor agonist mechanism across GLP-1, GIP, and GCGR, Phase 2 Read more Retatrutide (LY3437943): Mechanisms, Evidence, and Research Potential of the GIP/GLP-1/Glucagon Tri-Agonist